A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 67,630 shares of LLY stock, worth $54.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
67,630
Previous 72,631 6.89%
Holding current value
$54.9 Million
Previous $65.8 Million 8.88%
% of portfolio
0.14%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $3.86 Million - $4.8 Million
-5,001 Reduced 6.89%
67,630 $59.9 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $52.6 Million - $66 Million
72,631 New
72,631 $65.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.